SEC Form D filing
GT Biopharma, Inc.
Biotech · Seed · Regulation D 506(b) · CA · Filed March 7, 2025
Offering amount
$1.3M
Exemption
Reg D 506(b)
Issuer state
CA
Filing date
March 7, 2025
Signature date
—
CIK
0000109657
Summary
$1.28M offering for biopharmaceutical development company.
Source
FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.